FRAMINGHAM, Mass.–(BUSINESS WIRE)–SCIEX, a global leader in life science analytical technologies, announces the localization of its X500R QTOF system, ZenoTOF 7600 system, and ZenoTOF 7600+ system in China. This strategic advancement underscores the company’s continued commitment to accelerate localization efforts for its products in China, building upon the successful localization of the entire current triple quadrupole portfolio in Suzhou between 2023 and 2025.
The introduction of these additional high-resolution mass spectrometers represents a major step as SCIEX continues to combine global innovation with regional capabilities. By recognizing the teams in China with these localization efforts, SCIEX will enhance responsiveness, ensure greater product accessibility, and deliver world-class precision and performance tailored to the needs of the Chinese market.
The SCIEX accurate mass spectrometry portfolio is purpose-built for real-world problem solving, allowing scientists to use a range of quantitative and qualitative approaches to unlock new information. The Zeno trap, coupled with electron activated dissociation (EAD) fragmentation technology can unlock sensitivity gains, enabling enhanced performance across a multitude of accurate mass workflows.
Moving forward, SCIEX will continue to integrate cutting-edge global technologies with localized production and service excellence, providing customers with seamless, synchronized solutions that drive scientific progress, empowering science, locally and globally.
Learn more about the SCIEX accurate mass spectrometry portfolio by visiting here.
About SCIEX
SCIEX empowers our customers to solve the most impactful analytical challenges in quantitation and characterization. With groundbreaking innovation and outstanding reliability and support, SCIEX has been at the forefront of the field for over 50 years.
Since the launch of the first-ever commercially successful triple quadrupole in 1981, we continue to develop technologies and solutions that influence life-changing research and outcomes. That’s why thousands of life science experts around the world choose SCIEX to get the answers they can trust.
Advances in human wellness depend on the power of precise science.
For more information, visit sciex.com.
Connect with us on LinkedIn, Facebook, and Instagram.
SCIEX is proud to be part of Danaher.
Danaher’s science and technology leadership puts SCIEX solutions at the forefront of the industry, so they can reach more people. Being part of Danaher means we can offer unparalleled breadth and depth of expertise and solutions to our customers. Together with Danaher’s other businesses across Biotechnology, Diagnostics and Life Sciences, we unlock the transformative potential of cutting-edge science and technology to improve billions of lives every day.
The SCIEX clinical diagnostic portfolio is For In Vitro Diagnostic Use. Rx Only. Product(s) not available in all countries. For information on availability, please contact your local sales representative or refer to www.sciex.com/diagnostics. All other products are For Research Use Only. Not for use in Diagnostic Procedures.
Trademarks and/or registered trademarks mentioned herein, including associated logos, are the property of AB Sciex Pte. Ltd. or their respective owners in the United States and/or certain other countries (see www.sciex.com/trademarks).
© 2025 DH Tech. Dev. Pte. Ltd. MKT-36804-A.
Contacts
Contact Information
Lulu VanZandt
Senior Manager, Brand, Public Relations and Social Media
lulu.vanzandt@sciex.com
M: +1 (508) 782-9484
